Pēdējā atjaunošana :
22/08/2024
Infostab
Saraksti
Kopsavilkums
Meklēt saderības
Y-savienojuma saderības tabula
Literatūras saraksts
pētniecības grupas
valistab
plakāts
Savienojumi
sponsori
Autori
Lietošanas instrukcija
Newsletter
Ursodesoxycholique acid
Ķīmiskā uzbūve
Literatūras saraksts : Ursodesoxycholique acid
tips
publicēšana
2410
Žurnāls
Johnson CE, Streetman DD.
Stability of oral suspensions of ursodiol made from tablets
Am J Health-Syst Pharm 2002 ; 59: 361-363.
2449
Žurnāls
Johnson CE, Nesbitt J.
Stability of ursodiol in an extemporaneously compounded oral liquid
Am J Health-Syst Pharm 1995 ; 52: 1798-1800.
3782
Žurnāls
A. Santove?a, E. S?nchez-Negr?n, L. Charola, M. Llabr?s, J.B. Fari?a
Study of quality and stability of ursodeoxycholic acid formulations for oral pediatric administration
Int J Pharm 2014 , 477, 1-2 : 32-38.
4177
Žurnāls
Polonini H, Loures da Silva S, Fernandes Brandao M.A, Bauters T, De Moerloose B, De Oliveira Ferreira A.
Compatibility of Baclofen, Carvedilol, Hydrochlorothiazide, Mercaptopurine, Methadone Hydrochloride, Oseltamivir Phosphate, Phenobarbital, Propranolol Hydrochloride, Pyrazinamide, Sotalol Hydrochloride, Spironolactone, Tacrolimus Monohydrate, Ursodeoxycholic Acid, and Vancomycin Hydrochloride Oral Suspensions Compounded with SyrSpend SF PH4.
Int J Pharm Compound 2018 ;22,6:516-526
4214
Žurnāls
Pramar Y.V, Mandal T.K, Bostanian L.A, Nguyen A.TQ, Miller V, Morris T.C, Graves R.A.
Stability of Compounded Ursodiol Suspensions in PCCA Base, SuspendIt.
Int J Pharm Compound 2019 ;23,1:70-76
4498
Žurnāls
Hausherr A, Roessle C, Pinet E, Vasseur V, Abarou T, Benakouche S, Bourdon O, Storme T.
Development and validation of a new HPLC method for the analysis of a novel oral suspension formulation of 50 mg/mL ursodesoxycholic acid for newborns.
Pharmaceutical Technology in Hospital Pharmacy 2020
Mentions Légales